Medical Glossary

Key medical terms used in filler complication diagnosis and revision treatment.

AlloDerm (Acellular Dermal Matrix)
A human-derived tissue graft processed to remove cells while preserving the collagen scaffold. Used as an implant filler, it can cause chronic inflammation or capsule formation if the body rejects the material over time.
Aspiration Test
A safety check performed before filler injection by pulling back on the syringe plunger to verify the needle is not inside a blood vessel. While commonly practiced, it is not considered a fully reliable method to prevent vascular occlusion.
Autologous Fat (Fat Graft)
Fat harvested from the patient's own body and re-injected for facial volume. While biocompatible, over-injected fat can form oil cysts, calcified lumps, or irregular masses that require surgical extraction.
Biofilm
A protective layer of bacteria that forms on filler surfaces, shielding them from antibiotics and the immune system. Can remain dormant for years before causing chronic inflammation.
Blindness / Vision Loss
The most severe complication of filler injection, caused when filler material enters the retinal artery and blocks blood supply to the eye. This is an irreversible emergency most commonly associated with injections in the glabellar and nasal regions.
Bolus Injection
A technique where a large volume of filler is deposited in a single location at once, rather than distributed across multiple points. While useful for deep volume restoration, large boluses increase the risk of vascular occlusion and visible lumps.
Calcification
The process where soft tissue deposits (fat grafts, filler material) harden over time as calcium accumulates. Calcified lumps cannot be dissolved and require physical micro-fragmentation and extraction.
Calcium Hydroxylapatite (CaHA)
A semi-permanent filler (brand name Radiesse) made of calcium-based microspheres suspended in a gel carrier. It stimulates collagen production and cannot be dissolved by hyaluronidase. Complications require physical extraction.
Cannula vs. Needle
Two injection instruments with different safety profiles. A cannula has a blunt, flexible tip that pushes blood vessels aside, reducing vascular injury risk. A sharp needle penetrates tissue directly and offers more precision but carries higher risk of vessel puncture.
Chronic Inflammation
A prolonged immune response triggered by filler material the body cannot absorb or eliminate. Symptoms include persistent swelling, redness, tenderness, and hardening at the injection site, sometimes appearing months or years after injection.
Collagen Stimulator
Injectable fillers (Sculptra/PLLA, Ellansé/PCL, Radiesse/CaHA) that stimulate collagen production. Cannot be dissolved by hyaluronidase and may form persistent nodules requiring physical extraction.
Compression Therapy
A post-treatment technique using controlled external pressure to reduce swelling, limit filler re-migration, and support tissue healing after extraction procedures. Often combined with cooling to minimize bruising.
Cross-Linking Density
The degree of chemical bonds connecting HA polymer chains in a filler. Higher cross-linking makes the filler firmer, longer-lasting, and harder to dissolve. Heavily cross-linked fillers may resist hyaluronidase and require physical extraction.
Danger Zones (Facial Injection)
Facial areas with high risk of vascular occlusion during filler injection, including the glabellar region (between the eyebrows), nasal dorsum (nose bridge), and nasolabial folds. These zones contain dense networks of blood vessels connected to the ophthalmic artery.
Delayed-Onset Nodule
A firm lump that appears weeks to years after filler injection, caused by granuloma formation, biofilm infection, or filler clumping. Unlike immediate swelling, delayed nodules indicate a chronic tissue reaction that often requires extraction rather than dissolution.
Duplex Ultrasound
An ultrasound technique that combines standard tissue imaging with Doppler blood flow detection. Allows the physician to see filler deposits and surrounding blood vessels simultaneously, essential for safe extraction near major arteries.
Facial Overfilled Syndrome (FOS)
A clinical condition where repeated filler injections gradually alter facial proportions, causing puffy cheeks, stiff expressions, and blurred jawline. Often unnoticed by the patient due to "Filler Blindness."
Fibrous Capsule (Encapsulation)
A wall of fibrous tissue the body builds around filler material over time. Once formed, dissolvers cannot penetrate it. The capsule must be physically extracted along with the filler.
Filler Audit
A comprehensive assessment using high-frequency ultrasound to map all filler deposits in the face, including forgotten or migrated material. Provides a complete inventory before planning any extraction or corrective treatment.
Filler Blindness
The phenomenon where gradual filler accumulation makes it nearly impossible for patients to notice their own facial changes. Similar to how slow weight gain goes unnoticed.
Filler Embolism
A serious event where filler material enters a blood vessel and travels to block circulation in a distant area. Unlike localized vascular occlusion, an embolism can affect remote tissues including the retina, brain, or skin far from the injection site.
Filler Migration
Movement of injected filler material away from the original injection site over time, causing lumps, asymmetry, or unnatural contours in unintended areas.
Foreign Body Granuloma
A chronic inflammatory reaction where the immune system forms a mass of tissue around a foreign substance (filler material) it cannot eliminate. Requires physical extraction.
Functional Repair IV Therapy
A specialized intravenous protocol delivering high-dose anti-inflammatory agents, vasodilators, and tissue-repair nutrients directly into the bloodstream. Used as part of the vascular occlusion rescue protocol to support tissue recovery in the ischemic penumbra.
G' (G-Prime / Filler Viscosity)
A measure of a filler's elastic stiffness — how well it resists deformation and holds its shape. Higher G' fillers provide stronger structural support (e.g., chin, jawline) but are harder to dissolve or extract if complications arise.
High-Frequency Ultrasound
An imaging device operating at 15-50 MHz that provides exceptionally detailed visualization of skin layers and filler deposits. Used by Dr. Liu for real-time guidance during extraction to precisely locate material and avoid blood vessels.
Hyaluronidase
An enzyme used to dissolve hyaluronic acid (HA) filler. Cannot penetrate encapsulated nodules and also dissolves the patient's own native HA, potentially causing tissue depression.
Hyaluronic Acid (HA)
A naturally occurring sugar molecule used in the most common type of dermal filler. While theoretically dissolvable with hyaluronidase, heavily cross-linked or encapsulated HA filler can resist dissolution and require physical extraction.
Hyperbaric Oxygen Therapy (HBOT)
Breathing pure oxygen at 2.0-2.5 ATA pressure to increase plasma dissolved oxygen 10-15x, bypassing blocked vessels to deliver oxygen to ischemic tissue. Used in vascular occlusion recovery.
Ischemic Penumbra
The zone of tissue surrounding a vascular occlusion that receives reduced but not zero blood flow. These cells are salvageable with timely intervention (HBOT, functional repair IV therapy).
Lymphatic Obstruction
Blockage of lymphatic drainage channels by filler material, causing chronic puffiness, under-eye bags, or persistent swelling that does not respond to anti-inflammatory treatment. Common with repeated tear trough or cheek injections.
Micro-Fragmentation
A proprietary technique using microsurgical energy devices to break down calcified or solid filler deposits into extractable particles beneath the skin, enabling removal through a single pinhole.
MRI Filler Imaging
A magnetic resonance imaging technique using special sequences (STIR, T2-weighted) to detect and differentiate filler types within facial tissue. Useful for identifying deep or widespread filler deposits that ultrasound may not fully visualize.
Multi-Modal Recovery Protocol
A comprehensive treatment plan combining multiple therapies — such as HBOT, functional repair IV, photobiomodulation, and compression therapy — to maximize tissue recovery after filler extraction or vascular occlusion rescue.
Nasal Dorsum (Nose Bridge)
The bridge of the nose, a high-risk injection zone due to its limited blood supply and proximity to arteries feeding the eyes. Filler injected here can compress or enter the dorsal nasal artery, potentially causing skin necrosis or vision loss.
Nasolabial Fold
The crease running from the side of the nose to the corner of the mouth, one of the most commonly injected areas. Also a danger zone — the angular artery runs beneath the fold, and inadvertent injection into this vessel can cause serious vascular complications.
PAAG (Polyacrylamide Gel)
A permanent synthetic gel filler now banned in most countries due to severe long-term complications. PAAG can migrate extensively, cause chronic infection, and degrade into toxic monomers. Removal requires meticulous surgical extraction.
PCL (Polycaprolactone)
A biodegradable synthetic polymer used in the filler brand Ellansé. PCL microspheres stimulate collagen production for 1-4 years. Not dissolvable by any enzyme — if nodules or granulomas develop, physical extraction is the only effective treatment.
Photobiomodulation (PBM)
Use of specific wavelengths of red and near-infrared light to stimulate mitochondrial function, increase ATP production, and promote tissue regeneration in damaged skin.
PLLA (Poly-L-Lactic Acid)
A biodegradable synthetic polymer used in the filler brand Sculptra. It gradually stimulates collagen production over 2+ years. Cannot be dissolved by hyaluronidase — nodules or irregularities must be treated with physical extraction techniques.
Reticular Dermis
The deeper layer of the dermis containing dense collagen fibers, blood vessels, and structural support proteins. Filler injected too superficially into this layer can cause visible lumps or Tyndall effect, while injections below it may affect the SMAS.
Serial Puncture Technique
An injection method where small amounts of filler are deposited along a line through multiple closely-spaced needle insertions. Distributes product more evenly than bolus injection but creates multiple entry points that increase the risk of vessel damage.
Silicone (Liquid Injectable)
A permanent, non-biodegradable filler material. Liquid silicone cannot be dissolved or absorbed by the body and frequently causes severe granulomas, migration, and chronic inflammation years after injection. Removal requires extensive surgical extraction.
Single-Pinhole Extraction
A globally unique technique invented by Dr. Liu Ta-Ju that physically removes filler material through one needle-sized entry point (1-2mm) under real-time ultrasound guidance. No scalpel, no sutures.
Skin Necrosis
Death of skin tissue caused by blocked blood supply, typically from filler-induced vascular occlusion. Appears as discoloration progressing from white to purple to black. Early intervention is critical to minimize permanent scarring.
SMAS (Superficial Musculoaponeurotic System)
A continuous sheet of fibrous tissue and muscle beneath the facial skin that controls facial expressions. Filler injected near or into the SMAS can become trapped in this layer, making it particularly difficult to dissolve and often requiring physical extraction.
Staged Extraction
A treatment approach where filler removal is performed across multiple sessions rather than all at once. This allows tissue to heal between sessions, reduces the risk of volume collapse, and is recommended when large amounts of filler are present in multiple facial zones.
Tissue Atrophy
Thinning or wasting of skin and subcutaneous tissue, sometimes caused by excessive hyaluronidase injections that dissolve native tissue components, prolonged steroid use for nodule treatment, or chronic pressure from hardened filler deposits.
Tyndall Effect
A bluish discoloration visible under the skin when hyaluronic acid filler is injected too superficially. Light scatters through the transparent gel, creating a blue-gray tint. Most commonly seen in the under-eye (tear trough) area where skin is thin.
Vascular Occlusion
A serious complication where filler blocks blood flow to tissue, causing ischemia and potentially necrosis. Requires immediate emergency treatment and follow-up multi-modal recovery.